A Bayesian approach to establishang sample size and monitoring criteria for phase II clinical trials
Authors:
- Richard SimonRSRichard Simon
- 1 December 1994
- journal article
- clinical trial
- Published by Elsevier in Controlled Clinical Trials
- Vol. 15 (6) , 463-481
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Practical Bayesian Guidelines for Phase IIB Clinical Trials1994
- Sample Size Determination in Bayesian AnalysisJournal of the Royal Statistical Society: Series D (The Statistician), 1992
- Comparison of Bayesian with group sequential methods for monitoring clinical trialsControlled Clinical Trials, 1989
- Monitoring Clinical Trials Based on Predictive Probability of SignificanceBiometrics, 1989
- Optimal two-stage designs for phase II clinical trialsControlled Clinical Trials, 1989
- One-Sided Sequential Stopping Boundaries for Clinical Trials: A Decision- Theoretic Approach1988
- A predictive approach to selecting the size of a clinical trial, based on subjective clinical opinionStatistics in Medicine, 1986
- Interim analyses in clinical trials: Classical vs. bayesian approachesStatistics in Medicine, 1985
- Charts for the early stopping of pilot studies.Journal of Clinical Oncology, 1984
- Predictive Probability Early Termination Plans For Phase II Clinical TrialsBiometrics, 1979